Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02376699
Title Safety Study of SEA-CD40 in Cancer Patients
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Indications

Hodgkin's lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Advanced Solid Tumor

lymphoma

Therapies

Pembrolizumab + SEA-CD40

SEA-CD40

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.